JW Lifescience Corporation (KRX:234080)
12,960
+120 (0.93%)
Apr 24, 2026, 3:30 PM KST
JW Lifescience Revenue
In the year 2025, JW Lifescience had annual revenue of 257.83B KRW with 15.89% growth. JW Lifescience had revenue of 64.33B in the quarter ending December 31, 2025, with 17.40% growth.
Revenue
257.83B
Revenue Growth
+15.89%
P/S Ratio
0.77
Revenue / Employee
868.11M
Employees
297
Market Cap
198.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 257.83B | 35.35B | 15.89% |
| Dec 31, 2024 | 222.48B | 15.62B | 7.55% |
| Dec 31, 2023 | 206.86B | 17.93B | 9.49% |
| Dec 31, 2022 | 188.93B | 19.11B | 11.26% |
| Dec 31, 2021 | 169.82B | -13.70B | -7.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Suheung | 722.31B |
| Daewon Pharmaceutical | 605.43B |
| Jeil Pharmaceutical Co.,Ltd | 567.24B |
| Samjin Pharmaceuticals | 274.03B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| Whan In Pharm | 255.21B |
| Samil Pharmaceutical Co.,Ltd | 210.25B |
| Daihan Pharmaceutical | 208.61B |